![](/img/cover-not-exists.png)
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer
Halmos, B., Pennell, N. A., Fu, P., Saad, S., Gadgeel, S., Otterson, G. A., Mekhail, T., Snell, M., Kuebler, J. P., Sharma, N., Dowlati, A.Volume:
20
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2015-0136
Date:
November, 2015
File:
PDF, 825 KB
english, 2015